Table of Content

Open Access iconOpen Access

ARTICLE

Neurodevelopmental outcomes at 2 and 4 years in children with congenital heart disease

Cheryl L. Brosig1,2, Laurel Bear1,2, Sydney Allen1, Pippa Simpson1, Liyun Zhang1, Michele Frommelt1,2, Kathleen A. Mussatto2

1 Department of Pediatrics, Medical College of Wisconsin, Milwaukee, Wisconsin
2 Herma Heart Institute, Children’s Hospital of Wisconsin, Milwaukee, Wisconsin

* Corresponding Author: Cheryl Brosig, Medical College of Wisconsin, Department of Pediatrics, 8701 Watertown Plank Road, Milwaukee, WI 53226. Email: email

Congenital Heart Disease 2018, 13(5), 700-705. https://doi.org/10.1111/chd.12632

Abstract

Background and Objectives: Children with congenital heart disease (CHD) are at risk for neurodevelopmental (ND) delays. The purpose of this study is to compare the ND testing results of children with CHD at 2 and 4 years of age and determine if rates of ND delays change over time.
Methods: Children with CHD completed the Bayley Scales of Infant Development‐III (BSID‐III) at 2 years of age, and standardized neuropsychological measures at 4 years. Scores were compared with test norms and were classified as: average (within one SD of test mean); at risk (1‐2 SDs from the test mean); and delayed (>2 SD from test mean). Pearson correlations and McNemar’s exact tests were performed to deter‐ mine the relationship between test scores at the two times of assessment.
Results: Sixty‐four patients completed evaluations at 24 ± 3 months of age and 4 years of age. BSID‐III cognitive and fine motor scores were correlated with pre‐ school IQ and fine motor scores, r = .75 to .87, P < .0001. Agreement in score catego‐ ries was 79% for cognitive and 61% for fine motor. More patients had at risk or delayed scores at age 4 vs age 2 (P ≤ .01).
Conclusion(s): Despite significant correlations between 2‐ and 4‐year‐old test scores, many patients who scored in the average range at age 2 showed deficits at age 4. BSID‐III scores at age 2 may underestimate delays. Therefore, longitudinal ND as‐ sessment is recommended.

Keywords


Cite This Article

APA Style
Brosig, C.L., Bear, L., Allen, S., Simpson, P., Zhang, L. et al. (2018). Neurodevelopmental outcomes at 2 and 4 years in children with congenital heart disease. Congenital Heart Disease, 13(5), 700-705. https://doi.org/10.1111/chd.12632
Vancouver Style
Brosig CL, Bear L, Allen S, Simpson P, Zhang L, Frommelt M, et al. Neurodevelopmental outcomes at 2 and 4 years in children with congenital heart disease. Congeni Heart Dis. 2018;13(5):700-705 https://doi.org/10.1111/chd.12632
IEEE Style
C.L. Brosig et al., "Neurodevelopmental outcomes at 2 and 4 years in children with congenital heart disease," Congeni. Heart Dis., vol. 13, no. 5, pp. 700-705. 2018. https://doi.org/10.1111/chd.12632



cc Copyright © 2018 The Author(s). Published by Tech Science Press.
This work is licensed under a Creative Commons Attribution 4.0 International License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
  • 1341

    View

  • 1018

    Download

  • 0

    Like

Share Link